AFG3L2 Gene Spinocerebellar Ataxia Type 28 Autosomal Dominant NGS Genetic DNA Test
Introduction to the Test
The AFG3L2 Gene Spinocerebellar Ataxia Type 28 Autosomal Dominant NGS Genetic DNA Test is a specialized genetic test designed to detect mutations in the AFG3L2 gene, which are associated with hereditary spinocerebellar ataxia type 28 (SCA28). This test is crucial for patients exhibiting symptoms related to this neurological disorder and can provide invaluable information for diagnosis and management.
What the Test Measures
This genetic test measures the presence of specific mutations in the AFG3L2 gene. By utilizing Next Generation Sequencing (NGS) technology, it offers a comprehensive analysis of the gene, allowing for accurate identification of genetic variations that may contribute to the development of spinocerebellar ataxia.
Who Should Consider This Test?
The AFG3L2 Gene Spinocerebellar Ataxia Type 28 test is recommended for individuals who:
- Exhibit symptoms of spinocerebellar ataxia, such as balance issues, coordination problems, and difficulty with speech.
- Have a family history of neurological disorders, particularly those related to spinocerebellar ataxia.
- Are undergoing genetic counseling for hereditary conditions.
Benefits of Taking the Test
Taking the AFG3L2 Gene test offers several benefits:
- Accurate Diagnosis: Helps in confirming a diagnosis of spinocerebellar ataxia type 28.
- Informed Decision-Making: Provides critical information for treatment planning and management.
- Family Planning: Assists families in understanding hereditary risks and making informed choices.
Understanding Your Results
Once the test is completed, results will be interpreted by a qualified genetic counselor or neurologist. They will provide guidance on the implications of your results, including potential health management strategies and family planning options.
Test Pricing
| Test Name | Discount Price | Regular Price |
|---|---|---|
| AFG3L2 Gene Spinocerebellar Ataxia Type 28 Autosomal Dominant NGS Genetic DNA Test | 40,000 KSh | 56,000 KSh |
Sample Type and Instructions
This test requires a blood sample. Prior to testing, patients should undergo a genetic counseling session to discuss family history and draw a pedigree chart of affected family members.
Book Your Test Today!
We have branches across Kenya, including major cities such as Nairobi, Mombasa, and Kisumu. To book the AFG3L2 Gene Spinocerebellar Ataxia Type 28 Autosomal Dominant NGS Genetic DNA Test, please call or WhatsApp us at +254711564616.
